|
LM_ID
|
Common Name
|
Systematic Name
|
Species Shorthand
|
Formula
|
Mass
|
|
LMST01080069
|
|
3-O-(Rhaa1-3Glcb1-2(Xylb1-3)Glcb1-4Galb)-(25R)-5alpha-spirostan-3beta,6alpha,23S-triol
|
|
C56H92O28
|
1212.577520
|
|
LMST01080084
|
|
3-O-(Xylb1-3Glcb1-2(Xylb1-3)Glcb1-4Galb)-(25R)-12-oxo-5alpha-spirostan-3beta-ol
|
|
C55H88O27
|
1180.551305
|
|
LMST01080057
|
Gracillin
|
3-O-(Glcb1-3(Rhaa1-2)Glcb)-(25R)-spirost-5-en-3beta-ol
|
|
C45H72O17
|
884.476955
|
|
LMST01080070
|
|
6-O-(Glcb)-(25R)-5alpha-spirostan-3beta,6alpha,23S-triol
|
|
C33H54O10
|
610.371700
|
|
LMST01080078
|
Agavoside B
|
3-O-(Glcb1-4Galb)-(25R)-12-oxo-5alpha-spirostan-3beta-ol
|
|
C39H62O14
|
754.413960
|
|
LMST01080080
|
|
3-O-(Glcb1-2(Xylb1-3)Glcb1-4Galb)-(25R)-5alpha-spirostan-3beta-ol
|
|
C50H82O23
|
1050.524695
|
|
LMST01080090
|
|
3-O-(Rhaa1-2(Glcb1-4)Glcb)-(25R)-spirost-5en-3beta-ol
|
|
C45H72O17
|
884.476955
|
|
LMST01080072
|
Agavegenin A
|
(25R)-5alpha-spirostan-3beta,6alpha,11alpha,23S-tetrol
|
ST 28:1;O6
|
C27H44O6
|
464.313790
|
|
LMST01080086
|
Chlorogenin
|
(25R)-5alpha-spirostan-3beta,6alpha-diol
|
ST 28:1;O4
|
C27H44O4
|
432.323960
|
|
LMST01080063
|
Isonarthogenin
|
(25R)-spirost-5-en-3beta,27-diol
|
ST 28:2;O4
|
C27H42O4
|
430.308310
|
|
LMST01080089
|
Prosapogenin A
|
3-O-(Rhaa1-2Glcb)-(25R)-spirost-5en-3beta-ol
|
|
C39H62O12
|
722.424130
|
|
LMST01080058
|
Parrisaponin
|
3-O-(Rhaa1-4Rhaa1-4(Rhaa1-2)Glcb)-(25R)-spirost-5-en-3beta-ol
|
|
C51H82O20
|
1014.539950
|
|
LMST01080087
|
|
6-O-(Glcb)-(25R)-5alpha-spirostan-3beta,6alpha-diol
|
|
C33H54O9
|
594.376785
|
|
LMST01080071
|
|
3-O-(Glcb)-6-O-(Glcb)-(25R)-5alpha-spirostan-3beta,6alpha,23S-triol
|
|
C39H64O15
|
772.424525
|
|
LMST01070004
|
|
3-O-(Rhaa1-4Rhaa(Rhaa1-2)Glcb)-26-O-(Glcb)-22-methoxy-25(R)-furost-5-en-3beta,26-diol
|
|
C58H96O26
|
1208.618990
|
|
LMST01070007
|
Pseudoprotogracillin
|
3-O-(Glcb1-3(Rhaa1-2)Glcb)-26-O-(Glcb)-(25R)-furosta-5,20(22)-dien-3beta,26-diol
|
|
C51H82O22
|
1046.529780
|
|
LMST01080085
|
|
3-O-(Xylb1-3Glcb1-2(Glcb1-3)Glcb1-4Galb)-(25R)-12-oxo-5alpha-spirostan-3beta-ol
|
|
C57H94O27
|
1210.598255
|
|
LMST01070006
|
Dioscoreside E
|
3-O-(Glcb1-3(Rhaa1-2)Glcb)-26-O-(Glcb)-23S-methoxy-(25R)-furosta-5,20(22)-dien-3beta,26-diol
|
|
C52H84O23
|
1076.540345
|
|
LMST01070008
|
|
3-O-(Rhaa1-2Glcb)-26-O-(Glcb)-(25R)-furosta-5,20(22)-dien-3beta,26-diol
|
|
C45H72O17
|
884.476955
|
|
LMST01070009
|
Pseudoprotodioscin
|
3-O-(Rhaa1-4(Rhaa1-2)Glcb)-26-O-(Glcb)-(25R)-furosta-5,20(22)-dien-3beta,26-diol
|
|
C51H82O21
|
1030.534865
|
|
LMST01070012
|
|
3-O-(Rhaa1-4(Rhaa1-2)Glcb)-26-O-(Glcb)-(25R)-furost-5-en-3beta,22,26-triol
|
|
C51H84O22
|
1048.545430
|
|
LMST01070010
|
Dioscoreside C
|
3-O-(Rhaa1-4(Rhaa1-2)Glcb)-26-O-(Glcb)-23S-methoxy-(25R)-furosta-5,20(22)-dien-3beta,26-diol
|
|
C52H84O22
|
1060.545430
|
|
LMST01070014
|
Methyl protogracillin
|
3-O-(Glcb1-3(Rhaa1-2)Glcb)-26-O-(Glcb)-22-methoxy-(25R)-furost-5-ene-3beta,26-diol
|
|
C52H86O23
|
1078.555995
|
|
LMST01080094
|
Trillin
|
25R-Spirost-5-en-3beta-yl-beta-D-glucopyranoside
|
|
C33H52O8
|
576.366220
|
|
LMST01010349
|
1-(5alpha)-cholestenone
|
(5alpha)-cholest-1-en-3-one
|
ST 27:2;O
|
C27H44O
|
384.339215
|
|
LMST01010350
|
5, 20(22)-cholestadienol
|
Cholesta-5, 20(22)E-dien-3beta-ol
|
ST 27:2;O
|
C27H44O
|
384.339215
|
|
LMST01010351
|
4,6-cholestadienol
|
Cholesta-4,6-dien-3beta-ol
|
ST 27:2;O
|
C27H44O
|
384.339215
|
|
LMST01010352
|
4-cholestenol
|
Cholest-4-en-3beta-ol
|
ST 27:1;O
|
C27H46O
|
386.354865
|
|
LMST01010353
|
1,4-cholestadienone
|
Cholesta-1,4-dien-3-one
|
ST 27:3;O
|
C27H42O
|
382.323565
|
|
LMST01010354
|
4beta-OH-7-DHC
|
cholesta-5,7-dien-3beta,4beta-diol
|
ST 27:2;O2
|
C27H44O2
|
400.334130
|
|
LMST01010355
|
4alpha-OH-7-DHC
|
cholesta-5,7-dien-3beta,4alpha-diol
|
ST 27:2;O2
|
C27H44O2
|
400.334130
|
|
LMST01010356
|
24S-OH-7-DHC
|
cholesta-5,7-dien-3beta,24S-diol
|
ST 27:2;O2
|
C27H44O2
|
400.334130
|
|
LMST01010357
|
7-OOH-5,8-dien-3beta-ol
|
7alpha-hydroperoxy-cholesta-5,8-dien-3beta-ol
|
ST 27:2;O3
|
C27H44O3
|
416.329045
|
|
LMST01010358
|
EnP(5,8)
|
5alpha,8alpha-epidioxy-cholest-6-en-3beta-ol
|
ST 27:2;O3
|
C27H44O3
|
416.329045
|
|
LMST01010359
|
15beta-hydroxycholestane
|
5alpha-cholest-8(14)-an-3beta,15beta-diol
|
ST 27:0;O2
|
C27H48O2
|
404.365430
|
|
LMST01010360
|
Cholesterol-5beta-hydroperoxide
|
5beta-hydroperoxy-cholest-6-ene-3beta-ol
|
ST 27:1;O3
|
C27H46O3
|
418.344695
|
|
LMST01010361
|
22-iso-ecdysone
|
2beta,3beta,14alpha,22S,25-pentahydroxy-5beta-cholest-7-en-6-one
|
ST 27:2;O6
|
C27H44O6
|
464.313790
|
|
LMST01020039
|
16:3 Cholesterol ester
|
cholest-5-en-3beta-yl (7Z,10Z,13Z-hexadecatrienoate)
|
CE 16:3
|
C43H70O2
|
618.537580
|
|
LMST01020040
|
16:2 Cholesterol ester
|
cholest-5-en-3beta-yl (7Z,10Z-hexadecadienoate)
|
CE 16:2
|
C43H72O2
|
620.553230
|
|
LMST01020041
|
16:1 Cholesterol ester
|
cholest-5-en-3beta-yl (7Z-hexadecenoate)
|
CE 16:1
|
C43H74O2
|
622.568880
|
|
LMST01020042
|
22:3 Cholesterol ester
|
cholest-5-en-3beta-yl (10Z,13Z,16Z-docosatrienoate)
|
CE 22:3
|
C49H82O2
|
702.631480
|
|
LMST01020043
|
16:0 Campesterol ester
|
Campest-5-en-3beta-yl hexadecanoate
|
|
C44H78O2
|
638.600180
|
|
LMST01020044
|
18:0 Campesterol ester
|
campest-5-en-3beta-yl octadecanoate
|
|
C46H82O2
|
666.631480
|
|
LMST01020045
|
20:0 Campesterol ester
|
campest-5-en-3beta-yl eicosanoate
|
|
C48H86O2
|
694.662780
|
|
LMST01020046
|
22:0 Campesterol ester
|
campest-5-en-3beta-yl docosanoate
|
|
C50H90O2
|
722.694080
|
|
LMST01020047
|
16:0 Sitosterol ester
|
Stigmast-5-en-3beta-yl hexadecanoate
|
|
C45H80O2
|
652.615830
|
|
LMST01020048
|
18:0 Sitosterol ester
|
Stigmast-5-en-3beta-yl octadecanoate
|
|
C47H84O2
|
680.647130
|
|
LMST01020049
|
20:0 Sitosterol ester
|
Stigmast-5-en-3beta-yl eicosanoate
|
|
C49H88O2
|
708.678430
|
|
LMST01020050
|
22:0 Sitosterol ester
|
Stigmast-5-en-3beta-yl docosanoate
|
|
C51H92O2
|
736.709730
|
|
LMST01020051
|
22:0 Stigmasterol ester
|
Stigmast-5,22E-dien-3beta-yl docosanoate
|
|
C51H90O2
|
734.694080
|